Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications , an advisor to MedTech suppliers, chair of the Urology Trade Association, and governor of the Anscombe Bioethics Centre , looks ahead at what the coming year holds for the MedTech sector. The MedTech landscape in the UK and EU is set for significant developments in 2025, with a focus on regulatory changes, sustainability, innovation and the potential roll-out across the NHS in England of a switch to value-based procurement. UK Developments Regulatory Changes : The UK is revising its medical devices legislation , with new regulations expected to be implemented in 2025.
Further developments may include a framework to address advancements in medical device software and AI. NICE and the NHS are also developing a new MedTech pathway to streamline the approval and adoption process for innovative technologies. AI Integration : The Medicines and Healthcare products Regulatory Agency [MHRA] is developing processes like the "AI Airlock" to streamline the approval of AI-based medical technologies.
Investment and Innovation : Reports suggest that tax incentives for clinical trials and changes to tax rules and pension regulation could attract more investment and skilled professionals to the UK HealthTech sector. Circular Economy : The UK MedTech sector is increasingly adopting circular economy principles, focusing on sustainable product design, reusable devices, an.
